What is Psycamore?
Psycamore operates as a specialized provider of outpatient mental health treatment, addressing a critical gap in the healthcare continuum. By offering Intensive Outpatient Programs (IOP) and Partial Hospitalization Programs (PHP), the firm provides a structured, therapeutic alternative to traditional inpatient hospitalization. The company serves a diverse demographic, including adults, adolescents, and children, with a clinical focus on managing complex conditions such as anxiety and depression. Through a robust network of referrals from hospitals and educational institutions, Psycamore maintains a strong market position, emphasizing medical monitoring and family-integrated support systems to drive sustainable patient recovery.
How much funding has Psycamore raised?
Psycamore has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Psycamore
PPP
Public-Private Partnership
What's next for Psycamore?
The recent capital allocation is expected to catalyze the expansion of Psycamore's clinical infrastructure, allowing for broader geographic reach and enhanced service delivery. As the organization navigates this late-stage growth phase, the focus will likely shift toward optimizing patient throughput and integrating advanced therapeutic modalities. By leveraging this financing, Psycamore is well-positioned to address the rising demand for accessible, high-quality psychiatric care, potentially exploring digital health integrations or facility upgrades to maintain its competitive edge in the Mississippi healthcare landscape.
See full Psycamore company page
